Global Adalimumab Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery

October 2021 | 119 pages | ID: G1909E59D802EN
Maia Research

Abstracts

Adalimumab, sold under the brand name Humira among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis.

Based on the Adalimumab market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.

In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.

In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global Adalimumab market covered in Chapter 5:

Novartis AG
Biogen
Mylan
Sandoz
AbbVie
Pfizer
Boehringer Ingelheim
Amgen

In Chapter 6, on the basis of types, the Adalimumab market from 2015 to 2025 is primarily split into:

Rheumatoid Arthritis
Psoriatic Arthritis
Psoriasis
Crohn’s disease
Ulcerative colitis

In Chapter 7, on the basis of applications, the Adalimumab market from 2015 to 2025 covers:

Adults
Children

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:

North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa

Years considered for this report:

Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025

Contents

1 MARKET OVERVIEW

1.1 Product Definition and Market Characteristics
1.2 Global Adalimumab Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis

2. MARKET DYNAMICS

2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
  2.4.1 Short-term Impact
  2.4.2 Long-term Impact

3 ASSOCIATED INDUSTRY ASSESSMENT

3.1 Supply Chain Analysis
3.2 Industry Active Participants
  3.2.1 Suppliers of Raw Materials
  3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 MARKET COMPETITIVE LANDSCAPE

4.1 Industry Leading Players
4.2 Industry News
  4.2.1 Key Product Launch News
  4.2.2 M&A and Expansion Plans

5 ANALYSIS OF LEADING COMPANIES

5.1 Novartis AG
  5.1.1 Novartis AG Company Profile
  5.1.2 Novartis AG Business Overview
  5.1.3 Novartis AG Adalimumab Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.1.4 Novartis AG Adalimumab Products Introduction
5.2 Biogen
  5.2.1 Biogen Company Profile
  5.2.2 Biogen Business Overview
  5.2.3 Biogen Adalimumab Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.2.4 Biogen Adalimumab Products Introduction
5.3 Mylan
  5.3.1 Mylan Company Profile
  5.3.2 Mylan Business Overview
  5.3.3 Mylan Adalimumab Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.3.4 Mylan Adalimumab Products Introduction
5.4 Sandoz
  5.4.1 Sandoz Company Profile
  5.4.2 Sandoz Business Overview
  5.4.3 Sandoz Adalimumab Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.4.4 Sandoz Adalimumab Products Introduction
5.5 AbbVie
  5.5.1 AbbVie Company Profile
  5.5.2 AbbVie Business Overview
  5.5.3 AbbVie Adalimumab Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.5.4 AbbVie Adalimumab Products Introduction
5.6 Pfizer
  5.6.1 Pfizer Company Profile
  5.6.2 Pfizer Business Overview
  5.6.3 Pfizer Adalimumab Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.6.4 Pfizer Adalimumab Products Introduction
5.7 Boehringer Ingelheim
  5.7.1 Boehringer Ingelheim Company Profile
  5.7.2 Boehringer Ingelheim Business Overview
  5.7.3 Boehringer Ingelheim Adalimumab Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.7.4 Boehringer Ingelheim Adalimumab Products Introduction
5.8 Amgen
  5.8.1 Amgen Company Profile
  5.8.2 Amgen Business Overview
  5.8.3 Amgen Adalimumab Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.8.4 Amgen Adalimumab Products Introduction

6 MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPES

6.1 Global Adalimumab Sales, Revenue and Market Share by Types (2015-2020)
  6.1.1 Global Adalimumab Sales and Market Share by Types (2015-2020)
  6.1.2 Global Adalimumab Revenue and Market Share by Types (2015-2020)
  6.1.3 Global Adalimumab Price by Types (2015-2020)
6.2 Global Adalimumab Market Forecast by Types (2020-2025)
  6.2.1 Global Adalimumab Market Forecast Sales and Market Share by Types (2020-2025)
  6.2.2 Global Adalimumab Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Adalimumab Sales, Price and Growth Rate by Types (2015-2020)
  6.3.1 Global Adalimumab Sales, Price and Growth Rate of Rheumatoid Arthritis
  6.3.2 Global Adalimumab Sales, Price and Growth Rate of Psoriatic Arthritis
  6.3.3 Global Adalimumab Sales, Price and Growth Rate of Psoriasis
  6.3.4 Global Adalimumab Sales, Price and Growth Rate of Crohn’s disease
  6.3.5 Global Adalimumab Sales, Price and Growth Rate of Ulcerative colitis
6.4 Global Adalimumab Market Revenue and Sales Forecast, by Types (2020-2025)
  6.4.1 Rheumatoid Arthritis Market Revenue and Sales Forecast (2020-2025)
  6.4.2 Psoriatic Arthritis Market Revenue and Sales Forecast (2020-2025)
  6.4.3 Psoriasis Market Revenue and Sales Forecast (2020-2025)
  6.4.4 Crohn’s disease Market Revenue and Sales Forecast (2020-2025)
  6.4.5 Ulcerative colitis Market Revenue and Sales Forecast (2020-2025)

7 MARKET ANALYSIS AND FORECAST, BY APPLICATIONS

7.1 Global Adalimumab Sales, Revenue and Market Share by Applications (2015-2020)
  7.1.1 Global Adalimumab Sales and Market Share by Applications (2015-2020)
  7.1.2 Global Adalimumab Revenue and Market Share by Applications (2015-2020)
7.2 Global Adalimumab Market Forecast by Applications (2020-2025)
  7.2.1 Global Adalimumab Market Forecast Sales and Market Share by Applications (2020-2025)
  7.2.2 Global Adalimumab Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
  7.3.1 Global Adalimumab Revenue, Sales and Growth Rate of Adults (2015-2020)
  7.3.2 Global Adalimumab Revenue, Sales and Growth Rate of Children (2015-2020)
7.4 Global Adalimumab Market Revenue and Sales Forecast, by Applications (2020-2025)
  7.4.1 Adults Market Revenue and Sales Forecast (2020-2025)
  7.4.2 Children Market Revenue and Sales Forecast (2020-2025)

8 MARKET ANALYSIS AND FORECAST, BY REGIONS

8.1 Global Adalimumab Sales by Regions (2015-2020)
8.2 Global Adalimumab Market Revenue by Regions (2015-2020)
8.3 Global Adalimumab Market Forecast by Regions (2020-2025)

9 NORTH AMERICA ADALIMUMAB MARKET ANALYSIS

9.1 Market Overview and Prospect Analysis
9.2 North America Adalimumab Market Sales and Growth Rate (2015-2020)
9.3 North America Adalimumab Market Revenue and Growth Rate (2015-2020)
9.4 North America Adalimumab Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Adalimumab Market Analysis by Country
  9.6.1 U.S. Adalimumab Sales and Growth Rate
  9.6.2 Canada Adalimumab Sales and Growth Rate
  9.6.3 Mexico Adalimumab Sales and Growth Rate

10 EUROPE ADALIMUMAB MARKET ANALYSIS

10.1 Market Overview and Prospect Analysis
10.2 Europe Adalimumab Market Sales and Growth Rate (2015-2020)
10.3 Europe Adalimumab Market Revenue and Growth Rate (2015-2020)
10.4 Europe Adalimumab Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Adalimumab Market Analysis by Country
  10.6.1 Germany Adalimumab Sales and Growth Rate
  10.6.2 United Kingdom Adalimumab Sales and Growth Rate
  10.6.3 France Adalimumab Sales and Growth Rate
  10.6.4 Italy Adalimumab Sales and Growth Rate
  10.6.5 Spain Adalimumab Sales and Growth Rate
  10.6.6 Russia Adalimumab Sales and Growth Rate

11 ASIA-PACIFIC ADALIMUMAB MARKET ANALYSIS

11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Adalimumab Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Adalimumab Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Adalimumab Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Adalimumab Market Analysis by Country
  11.6.1 China Adalimumab Sales and Growth Rate
  11.6.2 Japan Adalimumab Sales and Growth Rate
  11.6.3 South Korea Adalimumab Sales and Growth Rate
  11.6.4 Australia Adalimumab Sales and Growth Rate
  11.6.5 India Adalimumab Sales and Growth Rate

12 SOUTH AMERICA ADALIMUMAB MARKET ANALYSIS

12.1 Market Overview and Prospect Analysis
12.2 South America Adalimumab Market Sales and Growth Rate (2015-2020)
12.3 South America Adalimumab Market Revenue and Growth Rate (2015-2020)
12.4 South America Adalimumab Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Adalimumab Market Analysis by Country
  12.6.1 Brazil Adalimumab Sales and Growth Rate
  12.6.2 Argentina Adalimumab Sales and Growth Rate
  12.6.3 Columbia Adalimumab Sales and Growth Rate

13 MIDDLE EAST AND AFRICA ADALIMUMAB MARKET ANALYSIS

13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Adalimumab Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Adalimumab Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Adalimumab Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Adalimumab Market Analysis by Country
  13.6.1 UAE Adalimumab Sales and Growth Rate
  13.6.2 Egypt Adalimumab Sales and Growth Rate
  13.6.3 South Africa Adalimumab Sales and Growth Rate

14 CONCLUSIONS AND RECOMMENDATIONS

14.1 Key Market Findings and Prospects
14.2 Advice for Investors

15 APPENDIX

15.1 Methodology
15.2 Research Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture
Figure Global Adalimumab Market Size and Growth Rate 2015-2025
Table Adalimumab Key Market Segments
Figure Global Adalimumab Market Revenue ($) Segment by Type from 2015-2020
Figure Global Adalimumab Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Adalimumab
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Novartis AG Company Profile
Table Novartis AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Novartis AG Production and Growth Rate
Figure Novartis AG Market Revenue ($) Market Share 2015-2020
Table Biogen Company Profile
Table Biogen Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Biogen Production and Growth Rate
Figure Biogen Market Revenue ($) Market Share 2015-2020
Table Mylan Company Profile
Table Mylan Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Mylan Production and Growth Rate
Figure Mylan Market Revenue ($) Market Share 2015-2020
Table Sandoz Company Profile
Table Sandoz Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Sandoz Production and Growth Rate
Figure Sandoz Market Revenue ($) Market Share 2015-2020
Table AbbVie Company Profile
Table AbbVie Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure AbbVie Production and Growth Rate
Figure AbbVie Market Revenue ($) Market Share 2015-2020
Table Pfizer Company Profile
Table Pfizer Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Pfizer Production and Growth Rate
Figure Pfizer Market Revenue ($) Market Share 2015-2020
Table Boehringer Ingelheim Company Profile
Table Boehringer Ingelheim Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Boehringer Ingelheim Production and Growth Rate
Figure Boehringer Ingelheim Market Revenue ($) Market Share 2015-2020
Table Amgen Company Profile
Table Amgen Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Amgen Production and Growth Rate
Figure Amgen Market Revenue ($) Market Share 2015-2020
Table Global Adalimumab Sales by Types (2015-2020)
Table Global Adalimumab Sales Share by Types (2015-2020)
Table Global Adalimumab Revenue ($) by Types (2015-2020)
Table Global Adalimumab Revenue Share by Types (2015-2020)
Table Global Adalimumab Price ($) by Types (2015-2020)
Table Global Adalimumab Market Forecast Sales by Types (2020-2025)
Table Global Adalimumab Market Forecast Sales Share by Types (2020-2025)
Table Global Adalimumab Market Forecast Revenue ($) by Types (2020-2025)
Table Global Adalimumab Market Forecast Revenue Share by Types (2020-2025)
Figure Global Rheumatoid Arthritis Sales and Growth Rate (2015-2020)
Figure Global Rheumatoid Arthritis Price (2015-2020)
Figure Global Psoriatic Arthritis Sales and Growth Rate (2015-2020)
Figure Global Psoriatic Arthritis Price (2015-2020)
Figure Global Psoriasis Sales and Growth Rate (2015-2020)
Figure Global Psoriasis Price (2015-2020)
Figure Global Crohn’s disease Sales and Growth Rate (2015-2020)
Figure Global Crohn’s disease Price (2015-2020)
Figure Global Ulcerative colitis Sales and Growth Rate (2015-2020)
Figure Global Ulcerative colitis Price (2015-2020)
Figure Global Adalimumab Market Revenue ($) and Growth Rate Forecast of Rheumatoid Arthritis (2020-2025)
Figure Global Adalimumab Sales and Growth Rate Forecast of Rheumatoid Arthritis (2020-2025)
Figure Global Adalimumab Market Revenue ($) and Growth Rate Forecast of Psoriatic Arthritis (2020-2025)
Figure Global Adalimumab Sales and Growth Rate Forecast of Psoriatic Arthritis (2020-2025)
Figure Global Adalimumab Market Revenue ($) and Growth Rate Forecast of Psoriasis (2020-2025)
Figure Global Adalimumab Sales and Growth Rate Forecast of Psoriasis (2020-2025)
Figure Global Adalimumab Market Revenue ($) and Growth Rate Forecast of Crohn’s disease (2020-2025)
Figure Global Adalimumab Sales and Growth Rate Forecast of Crohn’s disease (2020-2025)
Figure Global Adalimumab Market Revenue ($) and Growth Rate Forecast of Ulcerative colitis (2020-2025)
Figure Global Adalimumab Sales and Growth Rate Forecast of Ulcerative colitis (2020-2025)
Table Global Adalimumab Sales by Applications (2015-2020)
Table Global Adalimumab Sales Share by Applications (2015-2020)
Table Global Adalimumab Revenue ($) by Applications (2015-2020)
Table Global Adalimumab Revenue Share by Applications (2015-2020)
Table Global Adalimumab Market Forecast Sales by Applications (2020-2025)
Table Global Adalimumab Market Forecast Sales Share by Applications (2020-2025)
Table Global Adalimumab Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Adalimumab Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Adults Sales and Growth Rate (2015-2020)
Figure Global Adults Price (2015-2020)
Figure Global Children Sales and Growth Rate (2015-2020)
Figure Global Children Price (2015-2020)
Figure Global Adalimumab Market Revenue ($) and Growth Rate Forecast of Adults (2020-2025)
Figure Global Adalimumab Sales and Growth Rate Forecast of Adults (2020-2025)
Figure Global Adalimumab Market Revenue ($) and Growth Rate Forecast of Children (2020-2025)
Figure Global Adalimumab Sales and Growth Rate Forecast of Children (2020-2025)
Figure Global Adalimumab Sales and Growth Rate (2015-2020)
Table Global Adalimumab Sales by Regions (2015-2020)
Table Global Adalimumab Sales Market Share by Regions (2015-2020)
Figure Global Adalimumab Sales Market Share by Regions in 2019
Figure Global Adalimumab Revenue and Growth Rate (2015-2020)
Table Global Adalimumab Revenue by Regions (2015-2020)
Table Global Adalimumab Revenue Market Share by Regions (2015-2020)
Figure Global Adalimumab Revenue Market Share by Regions in 2019
Table Global Adalimumab Market Forecast Sales by Regions (2020-2025)
Table Global Adalimumab Market Forecast Sales Share by Regions (2020-2025)
Table Global Adalimumab Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Adalimumab Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Adalimumab Market Sales and Growth Rate (2015-2020)
Figure North America Adalimumab Market Revenue and Growth Rate (2015-2020)
Figure North America Adalimumab Market Forecast Sales (2020-2025)
Figure North America Adalimumab Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Adalimumab Market Sales and Growth Rate (2015-2020)
Figure Canada Adalimumab Market Sales and Growth Rate (2015-2020)
Figure Mexico Adalimumab Market Sales and Growth Rate (2015-2020)
Figure Europe Adalimumab Market Sales and Growth Rate (2015-2020)
Figure Europe Adalimumab Market Revenue and Growth Rate (2015-2020)
Figure Europe Adalimumab Market Forecast Sales (2020-2025)
Figure Europe Adalimumab Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Adalimumab Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Adalimumab Market Sales and Growth Rate (2015-2020)
Figure France Adalimumab Market Sales and Growth Rate (2015-2020)
Figure Italy Adalimumab Market Sales and Growth Rate (2015-2020)
Figure Spain Adalimumab Market Sales and Growth Rate (2015-2020)
Figure Russia Adalimumab Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Adalimumab Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Adalimumab Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Adalimumab Market Forecast Sales (2020-2025)
Figure Asia-Pacific Adalimumab Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Adalimumab Market Sales and Growth Rate (2015-2020)
Figure Japan Adalimumab Market Sales and Growth Rate (2015-2020)
Figure South Korea Adalimumab Market Sales and Growth Rate (2015-2020)
Figure Australia Adalimumab Market Sales and Growth Rate (2015-2020)
Figure India Adalimumab Market Sales and Growth Rate (2015-2020)
Figure South America Adalimumab Market Sales and Growth Rate (2015-2020)
Figure South America Adalimumab Market Revenue and Growth Rate (2015-2020)
Figure South America Adalimumab Market Forecast Sales (2020-2025)
Figure South America Adalimumab Market Forecast Revenue ($) (2020-2025)
Figure Brazil Adalimumab Market Sales and Growth Rate (2015-2020)
Figure Argentina Adalimumab Market Sales and Growth Rate (2015-2020)
Figure Columbia Adalimumab Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Adalimumab Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Adalimumab Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Adalimumab Market Forecast Sales (2020-2025)
Figure Middle East and Africa Adalimumab Market Forecast Revenue ($) (2020-2025)
Figure UAE Adalimumab Market Sales and Growth Rate (2015-2020)
Figure Egypt Adalimumab Market Sales and Growth Rate (2015-2020)
Figure South Africa Adalimumab Market Sales and Growth Rate (2015-2020)